Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GANIRELIX vs GEMTUZUMAB OZOGAMICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GANIRELIX vs GEMTUZUMAB OZOGAMICIN: Safety Overview

Metric GANIRELIX GEMTUZUMAB OZOGAMICIN
Total FAERS Reports 1,885 1,817
Deaths Reported 6 454
Death Rate 0.3% 25.0%
Hospitalizations 820 806
Average Patient Age 33.7 yrs 43.7 yrs
% Female Patients 99.5% 48.8%
FDA Approval Date Apr 23, 2025 N/A
Manufacturer Meitheal Pharmaceuticals Inc. Wyeth Pharmaceuticals LLC, a subsidia...
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription